Golub Capital BDC Reports First Quarter Fiscal 2026 Financial Results with Updates on Investment Strategy and Portfolio

2026-02-04|

Golub Capital BDC Reports First Quarter Fiscal 2026 Financial Results with Updates on Investment Strategy and Portfolio

by GOAI

Share To

Golub Capital BDC, Inc. released its financial results for the first quarter of fiscal year 2026 on February 4, 2026. The company provided detailed information regarding its performance during the reporting period, including key metrics and financial highlights.

The announcement included data on net investment income, total investment portfolio value, and net asset value per share. Golub Capital BDC also disclosed updates on its dividend distributions and portfolio activity for the quarter. The report highlighted changes in the company’s investment strategy and adjustments to its portfolio composition. Further details are available through the official statement linked to their announcement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

Author

GOAI

LATEST

NETSTREIT Corp Announces Upsized Forward Sale of 11 Million Shares at $18.90 Each

2026-02-11

Copart to Release Q2 Fiscal Year 2026 Financial Results on February 12 at 3:05 AM GMT

2026-02-11

BioRestorative Therapies Announces $5 Million Public Offering to Fund Operations

2026-02-11

Shriners Children’s Launches Multi-Center Study on Fractional CO2 Laser Technology for Pediatric Burn Care

2026-02-11

Rising Lung Cancer Cases Among Non-Smokers Linked to Genetic and Environmental Factors

2026-02-11

Path Planning Transformer Introduced to Enhance Multi-Robot Navigation in Complex Environments

2026-02-11

Amrize Corporation Appoints Three New Directors Following Departure of James Carter and Linda Nguyen

2026-02-11

EVENT

2026-02-09

World Health Expo Dubai

Dubai Exhibition Centre, Dubai

2026-02-17

BIO Asia 2026 (Life Science Partnerships)

Hyderabad, India

2026-02-24

Rare Disease Week on Capitol Hill (Policy and Advocacy)

Capitol Hill, Washington, D.C.

2026-03-09

HIMSS26 (Digital Health & Hospital IT)

Las Vegas, Nevada

2026-03-10

Bioprocessing Summit Europe (Biomanufacturing Trends)

Barcelona, Spain

2026-03-23

BIO Europe Spring (Biotech Partnering)

Lisbon, Portugal

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog